EmailHospital Circular 09/2003
Date Issued: 16 April 2003
Publication: 09/2003
Distribution: Public Hospitals
Subject: Highly Specialised Drugs Program
Purpose: To advise hospitals involved of changes to the Highly Specialised Drugs Program, effective 1 May 2003.
We have had recent advice from the Commonwealth of changes to the Highly Specialised Drugs Program, effective 1 May 2003.
1. ADD ITEM / DRUG FORM
Darbepoetin alfa
| 6365B | Injection 150 micrograms in 0.3 mL pre-filled syringe | 4 | $2,055.00 | Aranesp | AN |
Treatment of anaemia requiring transfusion, defined as a haemoglobin level of less than 100 g per L, associated with chronic renal failure, defined as a glomerular filtration rate of less than 60 mL per minute, where treatment is initiated by, or follows consultation by the prescriber with, a nephrologist.
2. DELETE
Interferon alfa-2b
| 6244P | Solution for injection 3,000,000 i.u. in 0.5 mL single dose vial | 5 | $140.54 | Intron A | SH |
| 6245Q | Solution for injection 5,000,000 i.u. in 0.5 mL single dose vial | 5 | $234.23 | Intron A | SH |
Items are being discontinued by manufacturer.
Noreen Dowd
Director
Programs Branch Metropolitan Health and Aged Care Services
